Assoc Dir, HEOR

Alkermes is seeking a highly motivated Associate Director, Health Economics & Outcomes Research (HEOR) to support the development and execution of HEOR strategies within its psychiatry portfolio.

This individual will lead the generation and communication of evidence demonstrating the clinical, economic, and patient-centered value of ARISTADA, Alkermes’ long-acting injectable for people living with schizophrenia. This individual will also support the Head of Psychiatry HEOR on other activities across the psychiatry franchise as needed.

Working closely with cross-functional partners, the successful candidate will support a broad range of HEOR activities, including generation of real-world evidence (RWE), health economic models and assessments, payer value communications, scientific presentations and publications, and other strategic support throughout the product lifecycle.

This position reports to the Head of Psychiatry HEOR and will collaborate extensively with Medical Affairs, Clinical Development, Market Access, Commercial, Legal, Regulatory, external research partners, and thought leaders. This role combines technical expertise, strategic thinking, and cross-functional collaboration.

Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.